Funders › NY › Paris Brain Institute America Inc C/O Martine Assouline › 2024
Grants paid by Paris Brain Institute America Inc C/O Martine Assouline, tax year 2024
EIN 92-2977507 · New York, NY · Form 990, Schedule I · NTEE H12
In tax year 2024, Paris Brain Institute America Inc C/O Martine Assouline (EIN 92-2977507) reported 3 grants paid totaling $266,874. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2024
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | Harvard University Boston, MA | A | $105,000 | paid | HARVARD MEDICAL SCHOOL: FOR THE BENEFIT OF DR. SANDRO SANTAGAT'S PROJECT, ENTITLED, "UNDERSTANDING AND OVERCOMING GLIOBLASTOMA THERAPEUTIC RESISTENCE" | 202503219349325170 |
| 2024 | Columbia University New York, NY | A | $97,000 | paid | VAGELOS COLLEGE OF PHYSICIANS AND SURGEONS, DEPARTMENT OF NEUROLOGY | 202503219349325170 |
| 2024 | Dana-Farber Cancer Institute Boston, MA | A | $64,874 | paid | PARTICIPATION IN THE PERFORMANCE OF THE RESEARCH PROJECT WITH THE AIM OF DEVELOPING NEW THERAPEUTIC STRATEGIES TO TACKLE GLIOBLASTOMAS, SPECIFICALLY TO IDENTIFY VULNARABILITIES IN THERAPY RESISTANCE AND DEVELOPING NEW TARGETED STRATEGIES FOR GLIOBLASTOMA | 202503219349325170 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.